**Correction to:** *Cell Death and Disease* (2016) **7**, e2419; 10.1038/cddis.2016.268, Published online 13 October 2016.

Since the publication of the article, the authors became aware that Fig. [6a, d](#Fig6){ref-type="fig"} contained errors in the bands and loading controls. The newly compiled Fig. [6a, d](#Fig6){ref-type="fig"} is given below.Fig. 6Knockdown of Mcl1 or Cdk4-induced cell cycle arrest and inhibited ES cell proliferation. **a** Mcl1 and Cdk4 siRNA analysis and expression check in murine and human ES cell lines resulted in upregulation of total RB and lower amount of pS780-RB. **b** Colony-forming assay in Matrigel displayed reduced clonogenic potency of EF-dependent cell lines after knockdown of Mcl1 or Cdk4 by siRNA treatment. **c** Cell cycle analysis of Mcl1 or Cdk4 siRNA treatment displayed enhanced G1 arrest. **d** In vitro growth inhibition of mouse and human EF-dependent cell lines by Palbociclib as well as the combinatorial treatment of Palbociclib and Obatoclax in triplicate. Cells were treated with inhibitors at the indicated concentration for 24 h. **e** CDK4/6 inhibition by Palbociclib displayed similar results as seen in the CDK4 siRNA assay

The authors apologise for any inconvenience caused.
